Propensity weighted indirect treatment comparison of nivolumab (NIVO) versus placebo (PBO) as adjuvant therapy for resected melanoma: A number needed to treat and overall survival analysis.

被引：0

作者：

Weber, Jeffrey S.

Poretta, Tayla

Stwalley, Brian

Sakkal, Leon

Du, Ella X.

Wang, Travis

Chen, Yan

Wang, Yan

Betts, Keith A.

Shoushtari, Alexander Noor

机构：

[1] NYU Langone Hlth, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA

[2] Bristol Myers Squibb, Lawrenceville, NJ USA

[3] Bristol Myers Squibb, Princeton, NJ USA

[4] Anal Grp Inc, Los Angeles, CA USA

[5] Anal Grp Inc, Boston, MA USA

[6] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.9572

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9572

引用

页数：3